KSQ Therapeutics

0 followers


KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.

Employees

11-50

Links

Org chart

Qasim Rizvi

Collapse
Chris Heberlig
Chief Financial Officer
Thomas Leitch
Chief Technology Officer
Micah Benson
Chief Scientific Officer
Andrew Wylie
SVP, Discovery Biology
Patty Martins Harris
SVP, Clinical Sciences
Dipen Sangurdekar
VP & Head of Data Sciences
Scott Goldman
VP, Portfolio Strategy & Operations
Lance Ostrom
VP, Head of Business Development